Law Firms Seek Ardent Health Lead Plaintiffs Ahead of March 9 Deadline

Plaintiffs say Ardent overstated receivables by using a 180-day write-off policy that obscured losses.

Overview

Investors who bought ARDT between July 18, 2024 and November 12, 2025 are being urged to come forward.
The lawsuits invoke Exchange Act §§10(b) and 20(a) and SEC Rule 10b-5.
Filings allege a 180-day cliff on accounts receivable, a lack of detailed historical collection reviews, and insufficient professional malpractice insurance.
On November 12, 2025 the company reported about $43 million in revenue reductions and a $54 million increase to professional liability reserves, and the stock fell roughly 33% the next day to $9.30.
The class is not yet certified, and firms including Schall and DJS are recruiting investors to seek lead-plaintiff status by March 9, though it is not required to participate in any recovery.